Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is an experimental small molecule with the IUPAC name "5-(4-fluorophenyl)-3-(4-methylbenzenesulfonamido)thiophene-2-carboxylic acid." It belongs to the class of organic compounds known as p-toluenesulfonamides and features a thiophene core substituted with a fluorophenyl group and a sulfonamide moiety. The molecular formula is C18H14FNO4S2 and its average molecular weight is approximately 391.44 g/mol. There are no approved therapeutic indications or detailed pharmacological data available for this compound in public drug databases; it appears to be used primarily in research settings as an experimental agent[1][6]. Its mechanism of action, clinical applications, developer information, and manufacturing details have not been established.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 5-(4-fluorophenyl)-3-{[(4-methylphenyl)sulfonyl]amino}thiophene-2-carboxylic acid.